Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 12/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | MRE11 | P49959 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CPT2 | P23786 | 1/20 | 0.39 |
| ▸ | CPT1A | P50416 | 1/20 | 0.39 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5585386 | 0.83 | CPT1A (0.46) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5999835 | 0.82 | HRH3 (0.45) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5585726 | 0.80 | HRH3 (0.48) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5585514 | 0.80 | HRH3 (0.48) | PTPN1FFAR1HRH3MRGPRX4PTPN2 | |
| SCHEMBL6000178 | 0.80 | HRH3 (0.44) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5585929 | 0.80 | CSNK2A1 (0.58) | PTPN1HRH3MRE11KDM4ENPC1 | |
| SCHEMBL5585872 | 0.79 | HRH3 (0.47) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5585882 | 0.79 | HRH3 (0.47) | PTPN1FFAR1HRH3MRGPRX4MRE11 | |
| SCHEMBL5585458 | 0.79 | HRH3 (0.44) | PTPN1FFAR1HRH3MRGPRX4KDM4E | |
| SCHEMBL5585378 | 0.79 | HRH3 (0.42) | PTPN1FFAR1HRH3MRGPRX4PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7163952-B2 | Azole compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2007-01-16 | — | — | US | disclosed |
| US-20050065196-A1 | Azole compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2005-03-24 | — | — | US | disclosed |
| EP-1452530-A1 | AZOLE COMPOUND AND MEDICINAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2004-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065196-A1 | Azole compound and medicinal use thereof | PTPN7, PTPN1, PTPN5 | PTPN1 2/4885FFAR1 868/4885HRH3 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.